世界の全身性エリテマトーデス(SLE)治療薬市場予測2021-2027:コルチコステロイド、非ステロイド性抗炎症治療薬(NSAID)、抗炎症治療薬、疾患修飾性抗リウマチ治療薬(DMARD)、抗マラリア治療薬、BLyS特異的阻害剤・モノクローナル抗体(MAbS)、免疫抑制剤・免疫調節剤、抗凝固剤

Market Monitor Globalが発行した調査報告書(MMG21DC17957)
◆英語タイトル:Systemic Lupus Erythematosus (SLE) Drugs Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21DC17957
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年12月
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥455,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥591,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

Market Monitor Global社が発行した本調査レポートは、世界の全身性エリテマトーデス(SLE)治療薬市場について調査し取りまとめました。全身性エリテマトーデス(SLE)治療薬の世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(コルチコステロイド、非ステロイド性抗炎症治療薬(NSAID)、抗炎症治療薬、疾患修飾性抗リウマチ治療薬(DMARD)、抗マラリア治療薬、BLyS特異的阻害剤・モノクローナル抗体(MAbS)、免疫抑制剤・免疫調節剤、抗凝固剤)、用途別分析(静脈内、亜皮膚、経口、局所)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界の全身性エリテマトーデス(SLE)治療薬市場規模2021年vs2027年
・世界の全身性エリテマトーデス(SLE)治療薬市場:売上予測2016年-2027年
・主要企業別の全身性エリテマトーデス(SLE)治療薬売上・市場シェア・価格
・全身性エリテマトーデス(SLE)治療薬の種類別市場規模:コルチコステロイド、非ステロイド性抗炎症治療薬(NSAID)、抗炎症治療薬、疾患修飾性抗リウマチ治療薬(DMARD)、抗マラリア治療薬、BLyS特異的阻害剤・モノクローナル抗体(MAbS)、免疫抑制剤・免疫調節剤、抗凝固剤
・全身性エリテマトーデス(SLE)治療薬の用途別市場規模:静脈内、亜皮膚、経口、局所
・地域別市場規模
・全身性エリテマトーデス(SLE)治療薬の北米市場:アメリカ市場、カナダ市場、メキシコ市場
・全身性エリテマトーデス(SLE)治療薬のヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・全身性エリテマトーデス(SLE)治療薬のアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・全身性エリテマトーデス(SLE)治療薬の南米市場:ブラジル市場、アルゼンチン市場など
・全身性エリテマトーデス(SLE)治療薬の中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:Anthera Pharmaceuticals、GSK、ImmuPharma、Johnson & Johnson
・世界の全身性エリテマトーデス(SLE)治療薬の生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・全身性エリテマトーデス(SLE)治療薬のサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of Systemic Lupus Erythematosus (SLE) Drugs in global, including the following market information:
Global Systemic Lupus Erythematosus (SLE) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Systemic Lupus Erythematosus (SLE) Drugs Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Systemic Lupus Erythematosus (SLE) Drugs companies in 2020 (%)
The global Systemic Lupus Erythematosus (SLE) Drugs market was valued at 168 million in 2020 and is projected to reach US$ 216.2 million by 2027, at a CAGR of 6.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Systemic Lupus Erythematosus (SLE) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Lupus Erythematosus (SLE) Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Systemic Lupus Erythematosus (SLE) Drugs Market Segment Percentages, By Type, 2020 (%)
Corticosteroids
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Anti-Inflammatories
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Antimalarials
BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
Immunosuppressive Agents/Immune Modulators
Anticoagulants

Global Systemic Lupus Erythematosus (SLE) Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Systemic Lupus Erythematosus (SLE) Drugs Market Segment Percentages, By Application, 2020 (%)
Intravenous
Sub-Cutaneous
Oral
Topical

Global Systemic Lupus Erythematosus (SLE) Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Systemic Lupus Erythematosus (SLE) Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Lupus Erythematosus (SLE) Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Systemic Lupus Erythematosus (SLE) Drugs revenues share in global market, 2020 (%)
Key companies Systemic Lupus Erythematosus (SLE) Drugs sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Systemic Lupus Erythematosus (SLE) Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anthera Pharmaceuticals
GSK
ImmuPharma
Johnson & Johnson

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 Systemic Lupus Erythematosus (SLE) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Systemic Lupus Erythematosus (SLE) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Systemic Lupus Erythematosus (SLE) Drugs Overall Market Size
2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size: 2021 VS 2027
2.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Systemic Lupus Erythematosus (SLE) Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Systemic Lupus Erythematosus (SLE) Drugs Players in Global Market
3.2 Top Global Systemic Lupus Erythematosus (SLE) Drugs Companies Ranked by Revenue
3.3 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue by Companies
3.4 Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Companies
3.5 Global Systemic Lupus Erythematosus (SLE) Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Systemic Lupus Erythematosus (SLE) Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Systemic Lupus Erythematosus (SLE) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Systemic Lupus Erythematosus (SLE) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Systemic Lupus Erythematosus (SLE) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Markets, 2021 & 2027
4.1.2 Corticosteroids
4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
4.1.4 Anti-Inflammatories
4.1.5 Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
4.1.6 Antimalarials
4.1.7 BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
4.1.8 Immunosuppressive Agents/Immune Modulators
4.1.9 Anticoagulants
4.2 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue & Forecasts
4.2.1 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2021
4.2.2 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2022-2027
4.2.3 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027
4.3 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Sales & Forecasts
4.3.1 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2021
4.3.2 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Sales, 2022-2027
4.3.3 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027
4.4 By Type – Global Systemic Lupus Erythematosus (SLE) Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2021 & 2027
5.1.2 Intravenous
5.1.3 Sub-Cutaneous
5.1.4 Oral
5.1.5 Topical
5.2 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue & Forecasts
5.2.1 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2021
5.2.2 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2022-2027
5.2.3 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027
5.3 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Sales & Forecasts
5.3.1 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2021
5.3.2 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Sales, 2022-2027
5.3.3 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027
5.4 By Application – Global Systemic Lupus Erythematosus (SLE) Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2021 & 2027
6.2 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue & Forecasts
6.2.1 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2021
6.2.2 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2022-2027
6.2.3 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027
6.3 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Sales & Forecasts
6.3.1 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2021
6.3.2 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Sales, 2022-2027
6.3.3 By Region – Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2027
6.4.2 By Country – North America Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2027
6.4.3 US Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.4.4 Canada Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.4.5 Mexico Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2027
6.5.2 By Country – Europe Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2027
6.5.3 Germany Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5.4 France Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5.5 U.K. Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5.6 Italy Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5.7 Russia Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.5.9 Benelux Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2027
6.6.2 By Region – Asia Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2027
6.6.3 China Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.6.4 Japan Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.6.5 South Korea Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.6.7 India Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2027
6.7.2 By Country – South America Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2027
6.7.3 Brazil Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.7.4 Argentina Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2027
6.8.3 Turkey Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.8.4 Israel Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
6.8.6 UAE Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Anthera Pharmaceuticals
7.1.1 Anthera Pharmaceuticals Corporate Summary
7.1.2 Anthera Pharmaceuticals Business Overview
7.1.3 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Major Product Offerings
7.1.4 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Anthera Pharmaceuticals Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Systemic Lupus Erythematosus (SLE) Drugs Major Product Offerings
7.2.4 GSK Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 ImmuPharma
7.3.1 ImmuPharma Corporate Summary
7.3.2 ImmuPharma Business Overview
7.3.3 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Major Product Offerings
7.3.4 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in Global (2016-2021)
7.3.5 ImmuPharma Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Major Product Offerings
7.4.4 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
8 Global Systemic Lupus Erythematosus (SLE) Drugs Production Capacity, Analysis
8.1 Global Systemic Lupus Erythematosus (SLE) Drugs Production Capacity, 2016-2027
8.2 Systemic Lupus Erythematosus (SLE) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Systemic Lupus Erythematosus (SLE) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Systemic Lupus Erythematosus (SLE) Drugs Supply Chain Analysis
10.1 Systemic Lupus Erythematosus (SLE) Drugs Industry Value Chain
10.2 Systemic Lupus Erythematosus (SLE) Drugs Upstream Market
10.3 Systemic Lupus Erythematosus (SLE) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Systemic Lupus Erythematosus (SLE) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

...

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の全身性エリテマトーデス(SLE)治療薬市場予測2021-2027:コルチコステロイド、非ステロイド性抗炎症治療薬(NSAID)、抗炎症治療薬、疾患修飾性抗リウマチ治療薬(DMARD)、抗マラリア治療薬、BLyS特異的阻害剤・モノクローナル抗体(MAbS)、免疫抑制剤・免疫調節剤、抗凝固剤(Systemic Lupus Erythematosus (SLE) Drugs Market - Global Outlook and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆